Top

Published in:

01-11-2011 | Original Communication

Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain–Barré syndrome patients

Authors: Christiane Caudie, Arnaud Quittard Pinon, Didier Taravel, Valérie Sivadon-Tardy, David Orlikowski, Flore Rozenberg, Tarek Sharshar, Jean Claude Raphaël, Jean Louis Gaillard

Published in: Journal of Neurology | Issue 11/2011

Abstract

We describe by an in-house dot immunoassay, specific anti-ganglioside and sulfatide antibodies, by comparing the results from a large group of 134 infected French GBS patients and those from 172 noninfected French GBS and 142 control groups. A recent infection was identified in 134/306 (43.8%) GBS patients: Campylobacter jejuni (24.6%) was the most common agent, followed by cytomegalovirus (12.4%), Mycoplasma pneumoniae (3.2%) and Epstein-Barr virus (1.3%). Anti-ganglioside antibodies were detected in 97/306 (31.7%) of total GBS patients, 82/134 (61.2%) of GBS patients with a recent identified infection and 15/172 (8.7%) of the patients without identified infection. According to the specificities and antibody classes, four specific IgG antibody profiles were individualised against the two major GM1 and GD1a gangliosides in motor axonal C. jejuni-associated GBS variants, against GQ1b and disialylated gangliosides in Miller Fisher syndrome and its variants. One specific IgM profile against GM2 was found in 16/38 (42%) of severe sensory demyelinating CMV-associated GBS and in 8/17 (47%) of subjects with recent CMV infection with no neurological disease. IgG or IgM antibodies to GM1 were found in 5/10 M. pneumoniae-infected patients. IgM antibodies to GM1 were observed in the control groups, 15% of the 74 patients with amyotrophic lateral sclerosis, 19% of the 51 patients with chronic inflammatory demyelinating polyneuropathy, and 9% of the 21 healthy control subjects. The fine specificity of the four IgG antibody profiles and the IgM anti-GM2 profile is closely related to the nature of the preceding infections and the pattern of clinical features.

Jacobs BC, Rothbarth PH, van der Meché FG, Herbrink P, Schmitz PI, de Klerk MA et al (1998) The spectrum of antecedent infections in Guillain–Barré syndrome. A case-control study. Neurology 51:1110–1115PubMed

Hadden RD, Karch H, Hartung HP, Zielasek J, Weissbrich B, Shubert J et al (2001) Preceding infections, immune factors and outcome in Guillain–Barré syndrome. Neurology 56:758–765PubMed

Yuki N, Taki T, Takahashi M, Saito K, Yoshino H, Tai T et al (1994) Molecular mimicry between GQ1b ganglioside and lipopolycaccharides of Campylobacter jejuni isolated from patients with Fisher’s syndrome. Ann Neurol 36:791–793PubMedCrossRef

Yuki N (2001) Infectious origins and molecular mimicry in Guillain–Barré and Fisher syndromes. Lancet Infect Dis 1:29–37PubMedCrossRef

Ilyas AA, Willison HJ, Quarles RH, Jungalwala FB, Cornblath DR, Trapp BD et al (1988) Serum antibodies to gangliosides in Guillain–Barré syndrome. Ann Neurol 23:440–447PubMedCrossRef

Alaedini Α, Briani C, Wirguin I, Siciliano G, D’Avino C, Latov N (2002) Detection of anti-ganglioside antibodies in Guillain–Barré syndrome and its variants by the agglutination assay. J Neurol Sci 196:41–44PubMedCrossRef

Chabraoui F, Derrington EA, Mallié-Didier F, Confavreux C (1993) Quincy Cl, Caudie C. Dot-blot immunodetection of antibodies against GM1 and other gangliosides on PVDF-P membrane. J Immunol Methods 165:225–230PubMedCrossRef

Caudie C, Reymond A, Antoine JC, Petiot P, Gonnaud PM, Vial C (2006) Screening for anti-glycolipid antibody profiles from patients with immune peripheral neuropathies by Dotzen^® Ganglio Profile antibodies. Ann Biol Clin Paris 64(2):149–156 FrenchPubMed

Caudie C, Vial C, Petiot P, Bouhour F (2010) Serum antibody profiles against gangliosides and sulfatide in peripheral neuropathies: evaluation of a new immunoassay. Ann Biol Clin Paris 68(6):675–680 FrenchPubMed

10.

Conrad K, Schneider H, Ziemssen T, Talaska T, Reinhold D, Humbel RL (2007) A new line immunoassay for the multiparametric detection of anti-ganglioside autoantibodies in patients with autoimmune peripheral neuropathies. Ann NY Acad Sci 1109:256–264PubMedCrossRef

11.

Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain–Barré syndrome. Ann Neurol 27(supl):S21–S24PubMedCrossRef

12.

Caudie C, Vial C, Bancel J, Petiot P, Antoine JC, Gonnaud PM (2002) Anti-ganglioside antibody profiles in Guillain–Barré syndrome. Ann Biol Clin Paris 60:589–597 FrenchPubMed

13.

Carpo M, Pedotti R, Allaria S, Lolli F, Matà S, Cavaletti G et al (1999) Clinical presentation and outcome of Guillain–Barré and related syndromes in relation to anti-ganglioside antibodies. J Neurol Sci 168(2):78–84PubMedCrossRef

14.

Hao Q, Saida T, Kuroki S, Nishimura M, Nukina M, Obayashi H et al (1998) Antibodies to gangliosides and galactocerebroside in patients with Guillain–Barré syndrome with preceding Campylobacter jejuni and other identified infections. J Neuroimmunol 81:116–126PubMedCrossRef

15.

Jacobs BC, van Doorn PA, Schmitz PIM et al (1996) Campylobacter jejuni infections and anti-GM1 antibodies in Guillain–Barré syndrome. Ann Neurol 40:181–187PubMedCrossRef

16.

Ho TW, Willison HJ, Nachamkin I, Li CY, Veitch J, Ung H et al (1999) Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain–Barré stndrome. Ann Neurol 45:168–173PubMedCrossRef

17.

Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N (2000) Axonal Guillain–Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 48:624–631PubMedCrossRef

18.

Drenthen J, Yuki N, Meulstee J, Maathuis EM, van Doorn PA, Visser GH et al (2011) Guillain–Barré syndrome subtypes related to Campylobacter infection. J Neurol Neurosurg Psychiatry 82(3):300–305PubMedCrossRef

19.

Carpo M, Pedotti R, Lolli F et al (1998) Clinical correlate and fine specificity of anti-GQ1b antibodies in peripheral neuropathy. J Neurol Sci 155:186–191PubMedCrossRef

20.

Yuki N, Taki T, Takahashi M, Saito K, Tai T, Miyatake T et al (1994) Penner’s serotype 4 of Campylobacter jejuni has a polysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1a epitope. Infect Immun 62:2101–2103PubMed

21.

Yuki N, Tagawa Y (1998) Acute cytomegalovirus infection and IgM anti-GM2 antibody. J Neurol Sci 154:14–17PubMedCrossRef

22.

Jacobs BC, van Doorn PA, Groeneveld JHM, Tio-Gillen AP, van der Meché FGA (1997) Cytomegalovirus infections and anti-GM2 antibodies in Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry 62:641–643PubMedCrossRef

23.

Khalili-Shirazi A, Gregson N, Gray IA, Rees JH, Winner JB, Hughes RAC (1999) Anti-ganglioside antibodies in Guillain–Barré syndrome after a recent cytomegalovirus infection. J Neurol Neurosurg Psychiatry 66:376–379PubMedCrossRef

24.

Susuki K, Odaka M, Mori M, Hirata K, Yuki N (2004) Acute motor axonal neuropathy after Mycoplasma infection: evidence of molecular mimicry. Neurology 62:949–956PubMed

25.

Kaida K, Morita D, Kanzaki M, Kamakura K, Motoyohi K, Hirakawa M (2007) Anti-ganglioside complex antibodies associated with severe disability in GBS. J Neuroimmunol 182(1–2):212–218PubMedCrossRef

26.

Kansaki M, Kaida K, Ueda M, Morita D, Hirakawa M, Motoyoshi K (2008) Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain–Barré syndromes. J Neurol Neurosurg Psychiatry 79(10):1148–1152CrossRef

Title: Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain–Barré syndrome patients
Authors: Christiane Caudie
Arnaud Quittard Pinon
Didier Taravel
Valérie Sivadon-Tardy
David Orlikowski
Flore Rozenberg
Tarek Sharshar
Jean Claude Raphaël
Jean Louis Gaillard
Publication date: 01-11-2011
Publisher: Springer-Verlag
Published in: Journal of Neurology / Issue 11/2011
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-011-6042-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain–Barré syndrome patients

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2011

Short- and long-lasting tinnitus relief induced by transcranial direct current stimulation

Response to immunotherapy in CLIPPERS syndrome

Congenital mirror movements: a clue to understanding bimanual motor control

Reversible abnormal functional neuroimaging presentations in polycythemia vera with chorea

Pisa syndrome as presenting symptom of amyotrophic lateral sclerosis

Progressive ascending myelopathy: atypical forms of multiple sclerosis or what else?